Alemtuzumab 1 of 6
Our research 2 of 6
Our people 3 of 6
For people with MS 4 of 6
The Cambridge Vision Lab 6 of 6
Welcome
Thank you for taking an interest in our work. We hope that you can find what we are looking for, whether you are a colleague scientist, a patient with neurological disease or generally interested. Please do not hesitate to contact us directly.
Featured News
CCMR2 A trial of a possible remyelinating treatment in multiple sclerosis Nerves in the brain and spinal cord are normally…
CCMR2 Trial will start in March 2022
Finally, our trial of metformin and clemastine is ready to start… or it will be when the placebo is manufactured…
Published in Lancet Neurology today, is our complete description of the bexarotene trial. It is a mixture of good and…